Cargando…

Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,

OBJECTIVE: To describe the prevalence of multidrug-resistant tuberculosis (MDR-TB) among tuberculosis patients in a major Brazilian city, evaluated via the Second National Survey on Antituberculosis Drug Resistance, as well as the social, demographic, and clinical characteristics of those patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Micheletti, Vania Celina Dezoti, Moreira, José da Silva, Ribeiro, Marta Osório, Kritski, Afranio Lineu, Braga, José Ueleres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083645/
https://www.ncbi.nlm.nih.gov/pubmed/24831400
http://dx.doi.org/10.1590/S1806-37132014000200009
_version_ 1782324405472329728
author Micheletti, Vania Celina Dezoti
Moreira, José da Silva
Ribeiro, Marta Osório
Kritski, Afranio Lineu
Braga, José Ueleres
author_facet Micheletti, Vania Celina Dezoti
Moreira, José da Silva
Ribeiro, Marta Osório
Kritski, Afranio Lineu
Braga, José Ueleres
author_sort Micheletti, Vania Celina Dezoti
collection PubMed
description OBJECTIVE: To describe the prevalence of multidrug-resistant tuberculosis (MDR-TB) among tuberculosis patients in a major Brazilian city, evaluated via the Second National Survey on Antituberculosis Drug Resistance, as well as the social, demographic, and clinical characteristics of those patients. METHODS: Clinical samples were collected from tuberculosis patients seen between 2006 to 2007 at three hospitals and five primary health care clinics participating in the survey in the city of Porto Alegre, Brazil. The samples were subjected to drug susceptibility testing. The species of mycobacteria was confirmed using biochemical methods. RESULTS: Of the 299 patients included, 221 (73.9%) were men and 77 (27.3%) had a history of tuberculosis. The mean age was 36 years. Of the 252 patients who underwent HIV testing, 66 (26.2%) tested positive. The prevalence of MDR-TB in the sample as a whole was 4.7% (95% CI: 2.3-7.1), whereas it was 2.2% (95% CI: 0.3-4.2) among the new cases of tuberculosis and 12.0% (95% CI: 4.5-19.5) among the patients with a history of tuberculosis treatment. The multivariate analysis showed that a history of tuberculosis and a longer time to diagnosis were both associated with MDR-TB. CONCLUSIONS: If our results are corroborated by other studies conducted in Brazil, a history of tuberculosis treatment and a longer time to diagnosis could be used as predictors of MDR-TB.
format Online
Article
Text
id pubmed-4083645
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format MEDLINE/PubMed
spelling pubmed-40836452014-07-16 Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil, Micheletti, Vania Celina Dezoti Moreira, José da Silva Ribeiro, Marta Osório Kritski, Afranio Lineu Braga, José Ueleres J Bras Pneumol Original Articles OBJECTIVE: To describe the prevalence of multidrug-resistant tuberculosis (MDR-TB) among tuberculosis patients in a major Brazilian city, evaluated via the Second National Survey on Antituberculosis Drug Resistance, as well as the social, demographic, and clinical characteristics of those patients. METHODS: Clinical samples were collected from tuberculosis patients seen between 2006 to 2007 at three hospitals and five primary health care clinics participating in the survey in the city of Porto Alegre, Brazil. The samples were subjected to drug susceptibility testing. The species of mycobacteria was confirmed using biochemical methods. RESULTS: Of the 299 patients included, 221 (73.9%) were men and 77 (27.3%) had a history of tuberculosis. The mean age was 36 years. Of the 252 patients who underwent HIV testing, 66 (26.2%) tested positive. The prevalence of MDR-TB in the sample as a whole was 4.7% (95% CI: 2.3-7.1), whereas it was 2.2% (95% CI: 0.3-4.2) among the new cases of tuberculosis and 12.0% (95% CI: 4.5-19.5) among the patients with a history of tuberculosis treatment. The multivariate analysis showed that a history of tuberculosis and a longer time to diagnosis were both associated with MDR-TB. CONCLUSIONS: If our results are corroborated by other studies conducted in Brazil, a history of tuberculosis treatment and a longer time to diagnosis could be used as predictors of MDR-TB. Sociedade Brasileira de Pneumologia e Tisiologia 2014 /pmc/articles/PMC4083645/ /pubmed/24831400 http://dx.doi.org/10.1590/S1806-37132014000200009 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Micheletti, Vania Celina Dezoti
Moreira, José da Silva
Ribeiro, Marta Osório
Kritski, Afranio Lineu
Braga, José Ueleres
Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
title Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
title_full Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
title_fullStr Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
title_full_unstemmed Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
title_short Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
title_sort drug-resistant tuberculosis in subjects included in the second national survey on antituberculosis drug resistance in porto alegre, brazil,
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083645/
https://www.ncbi.nlm.nih.gov/pubmed/24831400
http://dx.doi.org/10.1590/S1806-37132014000200009
work_keys_str_mv AT michelettivaniacelinadezoti drugresistanttuberculosisinsubjectsincludedinthesecondnationalsurveyonantituberculosisdrugresistanceinportoalegrebrazil
AT moreirajosedasilva drugresistanttuberculosisinsubjectsincludedinthesecondnationalsurveyonantituberculosisdrugresistanceinportoalegrebrazil
AT ribeiromartaosorio drugresistanttuberculosisinsubjectsincludedinthesecondnationalsurveyonantituberculosisdrugresistanceinportoalegrebrazil
AT kritskiafraniolineu drugresistanttuberculosisinsubjectsincludedinthesecondnationalsurveyonantituberculosisdrugresistanceinportoalegrebrazil
AT bragajoseueleres drugresistanttuberculosisinsubjectsincludedinthesecondnationalsurveyonantituberculosisdrugresistanceinportoalegrebrazil